Clinical Trials
5 articles
AI Advancements Revolutionizing Regenerative Medicine
Insilico Medicine's Rentosertib, an oral small-molecule inhibitor for idiopathic pulmonary fibrosis (IPF), progressed from discovery to a Phase III clinical trial in record time.
How AI is Accelerating Drug Discovery and Vaccine Development
In a remarkable acceleration, AI helped Insilico achieve a 30-month sprint from target identification to a Phase I clinical trial candidate, a process that traditionally takes years longer, according
How Nexus Scientific Solutions, LLC Uses NSSCertiTrial™ and Empirio™ to Simplify Clinical Research Operations
Nexus Scientific Solutions, LLC uses NSSCertiTrial™ and Empirio™ to simplify clinical research operations by providing a centralized platform for managing studies, participant workflows, and documentation. These products aim to replace fragmented, spreadsheet-dependent systems with organized research and clinical operations.
AI accelerates oncology trials, FDA shapes AI-driven research
A novel AI-generated TNIK inhibitor recently completed a Phase 2a trial for idiopathic pulmonary fibrosis, demonstrating AI's shift from data analysis to active therapeutic compound design.
How Machine Learning Speeds Drug Discovery in Clinical Trials
80% of clinical trials miss their timelines, imposing daily costs of up to $8 million on pharmaceutical companies, according to Nature .